Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives

Affiliations

¹ The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.
² Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.

Alex Zhavoronkov et al. Front Genet. 2016.

. 2016 Feb 16:7:17.

doi: 10.3389/fgene.2016.00017. eCollection 2016.

¹ The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.
² Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.

No abstract available

Keywords: ICD-11; WHO; aging disease; biogerontology; geroprotectors; longevity risk.

Comment on

Editorial on Research Topic Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives

1. Aliper A. M., Csoka A. B., Buzdin A., Jetka T., Roumiantsev S., Moskalev A., et al. . (2015). Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging 7, 26–37. - PMC - PubMed
1. Duncan D. E. (2012). How Long Do You Want To Live? New York, NY: N. Y. Times.
1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. . (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128. 10.1016/S0140-6736(12)61728-0) - DOI - PMC - PubMed
1. Makarev E., Cantor C., Zhavoronkov A., Buzdin A., Aliper A., Csoka A. B. (2014). Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany. NY). 6, 1064–1075. - PMC - PubMed
1. Moskalev A. A., Aliper A. M., Smit-McBride Z., Buzdin A., Zhavoronkov A. (2014). Genetics and epigenetics of aging and longevity. Cell Cycle 13, 1063–1077. 10.4161/cc.28433 - DOI - PMC - PubMed